On January 31, 2017, Aflofarm Pharmacy Poland signed the Code of Good Practice for Advertising of Dietary Supplements. The primary purpose of the Code is to ensure the reliability of information provided to consumers and to develop industry-standard advertising standards.

On January 31, 2017, Aflofarm Pharmacy Poland signed the Code of Good Practice for Advertising of Dietary Supplements. The primary purpose of the Code is to ensure the reliability of information provided to consumers and to develop industry-standard advertising standards. The idea of ​​creating a Code of Good Practice was created by manufacturers and distributors of supplements. Autoregulation has been worked out by four trade organizations - the National Council of Supplements and Nutrition, the Polish Federation of Manufacturers of Non-Prescription Medicines, the Federation of Producers and Distributors Supplements Polska and Polfarmed, the Polish Chamber of Pharmaceutical Industry and Medical Devices. Aflofarm, which is a member of the latter and one of the leaders in the pharmaceutical market in Poland, has joined the signatories of the Code. - It rests on us as the company that is the leader in the OTC segment and the biggest advertiser in the country, responsible for shaping positive market standards. Although from the very beginning of the company's activity our most important product category is the drug, the company's portfolio also includes supplements, so we decided to join the Code. We want the message addressed to our consumers to be legible and the features of our products are presented in a reliable and unmistakable way, "explains Jacek Furman, president of Aflofarm Pharmaceuticals Poland. The Code of Good Practice for Advertising of Dietary Supplements contains a number of provisions that impose additional obligations on supplements manufacturers to advertise supplements. Among the rules that will regulate the Code is, among others. legible and uniform for all these types of advertising in the advertising that the product is a dietary supplement and a prohibition on advertising in disease supplements, in such a way as to indicate the medicinal properties of the product. The Code also excludes the use of a doctor's image in advertising spots for supplements, as well as restrictions on ads targeted at children. Companies that are members of Code Initiatives hold up to 80% of the market share of diet supplements advertising, and their adherence to the Code has been entirely voluntary. In view of the commitments made before the Code's appearance, each signatory has 6 months to implement and adapt the ads to self-regulatory records.